Sabine Taschner-Mandl is elected to the executive board of Europe’s neuroblastoma network SIOPEN

Sabine Taschner-Mandl is elected to the executive board of Europe’s neuroblastoma network SIOPEN

(Vienna, 20.10.2021) Developing new therapies for childhood nerve tumors and identifying more molecular markers for better diagnosis – this is what Sabine Taschner-Mandl strives for in her new role as Executive Committee Board Member of the European Neuroblastoma Research Group SIOPEN. Sabine Taschner-Mandl, PhD, head of the Tumor Biology Research…

EU Commissioner visits St. Anna: "Europe’s Beating Cancer Plan puts the spotlight on childhood cancer"

EU Commissioner visits St. Anna: "Europe’s Beating Cancer Plan puts the spotlight on childhood cancer"

(Vienna, 08.09.2021) Childhood cancer is different from cancer in adults. Thus, it needs research specifically tailored to pediatric tumors, which requires dedicated funding. The need for medicines suitable for children, as well as improvements in long-term follow-up care for cancer survivors have been discussed with EU Health Commissioner Stella Kyriakides,…

Kaan Boztug awarded the "Işil Berat Barlan Award for Primary Immunodeficiency Diseases"

Kaan Boztug awarded the "Işil Berat Barlan Award for Primary Immunodeficiency Diseases"

(Vienna, 03.09.2021) Congratulations! Assoc.-Prof. Kaan Boztug, MD, Scientific Director of the St. Anna Children's Cancer Research Institute and Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, has been awarded the Işil Berat Barlan Award for his outstanding research in the field of primary immunodeficiencies, which will be…

Childhood Cancer Awareness Month 2021 - St. Anna CCRI under the sign of the gold ribbon

Childhood Cancer Awareness Month 2021 - St. Anna CCRI under the sign of the gold ribbon

(Vienna, 01.09.2021) With our research, we aim to strike childhood cancer at its roots. In Austria, about 200 children and 100 adolescents are diagnosed with cancer each year. Thanks to research and the resulting major advances in treatment, 85% of affected children and adolescents are cured. However, about 30 children…

“Our results can have a direct impact on a child’s life”

“Our results can have a direct impact on a child’s life”

(Vienna, 17.8.2021) Together with colleagues, Artem Kalinichenko (37) discovered a novel gene defect causing a life-threatening immune disorder. Profiled as a YoungStar by St. Anna Children’s Cancer Research Institute (St. Anna CCRI), the scientist explains how to form a good hypothesis and under which circumstances he acquires aha-experiences. Artem Kalinichenko,…